TLR4 and idiopathic dilated cardiomyopathy: This suggests that genetic factors, specifically TLR4 variants, may play a role in determining the therapeutic response to statins and cardiovascular outcomes.[47] The study by Tesson et al characterized a unique genetic variant in the beta1-adrenoceptor gene and evaluated its association with idiopathic dilated cardiomyopathy.